Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics | $4.15 | $1.43 | 52.57% | 711.1K | $663M | $0.86$4.25 |
| SKYQ | Sky Quarry | $18.71 | $6.12 | 48.61% | 9.1M | $47M | $1.66$19.45 |
| ALMU | Aeluma | $15.10 | $4.34 | 40.34% | 62.2K | $194M | $6.08$25.88 |
| JDZG | Jiade | $2.11 | $0.59 | 38.64% | 15.2M | $2.2M | $1.46$158.00 |
| RVMD | Revolution Medicines | $131.11 | $34.68 | 35.96% | 3.2M | $19B | $34.00$132.55 |
| SYRE | Spyre Therapeutics | $67.45 | $16.16 | 31.51% | 1.2M | $4.0B | $12.04$75.00 |
| CLLS | Cellectis | $4.40 | $0.81 | 22.56% | 1.8K | $260M | $1.33$5.48 |
| IDYA | IDEAYA Biosciences | $36.57 | $6.07 | 19.90% | 160.2K | $2.7B | $15.84$39.28 |
| OPTX | Syntec Optics | $11.15 | $1.80 | 19.25% | 674.9K | $346M | $1.04$11.35 |
| ANNA | AleAnna | $5.71 | $0.72 | 14.49% | 2.7M | $203M | $2.31$18.30 |
| XNDU | Xanadu Quantum Technologies | $10.15 | $1.19 | 13.23% | 129.5K | $203M | $6.97$12.80 |
| MVO | Mv Oil Trust | $3.10 | $0.36 | 13.14% | 140.7K | $32M | $0.97$6.40 |
| TBRG | TruBridge | $20.26 | $2.28 | 12.68% | 107K | $268M | $13.88$26.74 |
| LEG | Leggett & Platt | $11.08 | $1.09 | 10.91% | 970.7K | $1.4B | $6.48$13.00 |
| KGEI | Kolibri Global Energy | $5.58 | $0.54 | 10.71% | 30.5K | $179M | $3.35$8.27 |
| WTI | W&T Offshore | $3.04 | $0.28 | 10.31% | 1.9M | $411M | $1.11$4.04 |
| IMA | ImageneBio | $5.38 | $0.48 | 9.76% | 12.5M | $55M | $3.94$18.00 |
| PRTC | PureTech Health Plc | $17.90 | $1.40 | 8.48% | 5.5K | $402M | $14.50$19.92 |
| CRWG | Themes ETF Trust - Leverage Shares 2x Long Crwv Daily ETF | $4.36 | $0.34 | 8.46% | 9.7M | - | $1.80$19.63 |
| BBGI | Beasley Broadcast Group | $12.55 | $0.79 | 6.75% | 245.7K | $21M | $3.14$26.37 |
| LICN | Lichen International | $3.39 | $0.20 | 6.27% | 3.2K | $52M | $2.57$8.28 |
| BTM | Bitcoin Depot | $2.77 | $0.14 | 5.32% | 27.4K | $29M | $1.91$48.16 |
| NETG | Themes ETF Trust - Leverage Shares 2x Long Net Daily ETF | $8.04 | $0.39 | 5.10% | 140.1K | - | $7.40$15.17 |
| BEEP | Mobile Infrastructure | $2.27 | $0.11 | 4.86% | 1.6K | $89M | $2.00$4.67 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $27.32 | $1.15 | 4.39% | 179.3K | - | $20.21$157.62 |
| FUSE | Fusemachines | $1.89 | $0.06 | 3.28% | 3.1M | $53M | $0.80$4.25 |
| CRCG | Themes ETF Trust - Leverage Shares 2x Long Crcl Daily ETF | $2.33 | $0.06 | 2.42% | 2.9M | - | $0.95$20.92 |
| NXPL | NextPlat | $4.83 | -$0.08 | -1.65% | 59.2 | $131M | $3.38$11.10 |
| GDEV | Gdev | $13.72 | -$0.27 | -1.93% | 49.6 | $249M | $10.19$42.20 |
| DCOY | Decoy Therapeutics | $5.84 | -$0.16 | -2.67% | 244.9 | $3.1M | $5.40$415.80 |
| FLYE | Fly-E Group | $2.15 | -$0.13 | -5.70% | 0 | $3.4M | $1.68$161.80 |
Related Articles
Featured Article
This 7.5% Yielding Dividend King Manages Tough Times Just Fine
Reuben Gregg Brewer|Nov 9, 2023
With a historically high dividend yield and a struggling business, investors wonder if this Dividend King is OK to buy.
I Just Bought This High Yield Dividend King and Things Have Gotten Worse
Reuben Gregg Brewer|Aug 31, 2023
Leggett & Platt is a new addition to my portfolio, but I bought it thinking I'd rather be about right than miss the long-term opportunity.
Here's Why I Bought This Struggling Stock
Reuben Gregg Brewer|Jun 2, 2023
I was looking for an industrial stock to replace 3M in my portfolio and decided that Leggett & Platt would fit the bill.
Is This Under-the-Radar Dividend Stock a Buy?
Kody Kester|Aug 31, 2022
Leggett & Platt is a well-established yet largely unknown dividend stock.
This Unofficial Dividend King Is a Great Stock for Income Investors
Kody Kester|Apr 8, 2022
Leggett & Platt flies under the radar for most dividend investors. But it shouldn't.
This 2020 Biotech IPO Is Poised to Break Out in 2021
Patrick Bafuma|Apr 2, 2021
Revolution Medicines' leading compound is shaping up to be a platform in a pill.
4 Companies That Could Upend the Pharma Industry
James Halley|Jul 29, 2020
Their groundbreaking research on CAR T-cell therapies could revolutionize how certain cancers are treated in the future.
3 Healthcare Stocks That Surged Last Week
Cory Renauer|Jun 21, 2020
Here's what pushed up shares of the highest-flying healthcare stocks.
2 Top Stocks Under $5
Taylor Carmichael|Jun 19, 2020
Here's why you might want to invest in Planet 13 and W&T Offshore.
These 3 Dividend Aristocrats Could Lose Their Royal Status
Jeremy Bowman|Apr 26, 2020
Even the most reliable dividend stocks could struggle to pay investors this year.
